IRLAB to Present at BioStock Global Forum 2025

Gothenburg, Sweden, May 15, 2025 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson’s disease, today announces that CEO Kristina Torfgård will present IRLAB to potential partners and specialist investors at BioStock Global Forum 2025. The event will take place on May 20-21 in Lund, Sweden.

IRLAB is granted a patent expanding the patent protection for the drug candidate mesdopetam in the US

Notice to the Annual General Meeting in IRLAB Therapeutics AB